Back to Search Start Over

Adaptive servo-ventilation: How does it fit into the treatment of central sleep apnoea syndrome? Expert opinions

Authors :
Pascaline Priou
Renaud Tamisier
Jean-Claude Meurice
T. Gentina
Jean-Louis Pépin
Thibaud Damy
Jean-Marc Davy
M.-P. d’Ortho
C. Philippe
Frédéric Gagnadoux
Stress Oxydant et Pathologies Métaboliques (SOPAM)
Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Institut Mondor de Recherche Biomédicale (IMRB)
Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
Service de pneumologie
Centre hospitalier universitaire de Poitiers (CHU Poitiers)
CHU Grenoble
CHU Pitié-Salpêtrière [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Source :
Revue des Maladies Respiratoires, Revue des Maladies Respiratoires, Elsevier Masson, 2015, 32 (10), pp.1072-1081. ⟨10.1016/j.rmr.2015.09.007⟩
Publisher :
SPLF. Published by Elsevier Masson SAS

Abstract

SummaryThe preliminary results of the SERVE-HF study have led to the release of safety information with subsequent contraindication to the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnoeas in patients with chronic symptomatic systolic heart failure with left ventricular ejection fraction (LVEF) ≤ 45%. The aim of this article is to review these results, and to provide more detailed arguments based on data from the literature advocating the continued use of ASV in different indications, including heart failure with preserved LVEF, complex sleep apnoea syndrome, opioid-induced central sleep apnea syndrome, idiopathic central SAS, and central SAS due to a stroke. Based on these findings, we propose to set up registers dedicated to patients in whom ASV has been stopped and in the context of the next setting up of ASV in these specific indications to ensure patient safety and allow reasoned decisions on the use of ASV.

Details

Language :
English
ISSN :
07618425 and 17762588
Issue :
10
Database :
OpenAIRE
Journal :
Revue des Maladies Respiratoires
Accession number :
edsair.doi.dedup.....db05e4b861d30dd419427a5489438817
Full Text :
https://doi.org/10.1016/j.rmr.2015.09.007